Iontophoresis-driven alterations in nanoparticle uptake pathway and intracellular trafficking in carcinoma skin cancer cells

Effective treatment of squamous cell carcinoma (SCC) poses challenges due to intrinsic drug resistance and limited drug penetration into tumor cells. Nanoparticle-based drug delivery systems have emerged as a promising approach to enhance therapeutic efficacy; however, they often face hurdles such a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Colloids and surfaces, B, Biointerfaces B, Biointerfaces, 2024-12, Vol.248, p.114459, Article 114459
Hauptverfasser: Galvão, Gabriela Fávero, Petrilli, Raquel, Arfelli, Vanessa Cristina, Carvalho, Andréia Nogueira, Martins, Yugo Araújo, Rosales, Roberta Ribeiro Costa, Archangelo, Leticia Fröhlich, daSilva, Luis Lamberti Pinto, Lopez, Renata Fonseca Vianna
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Effective treatment of squamous cell carcinoma (SCC) poses challenges due to intrinsic drug resistance and limited drug penetration into tumor cells. Nanoparticle-based drug delivery systems have emerged as a promising approach to enhance therapeutic efficacy; however, they often face hurdles such as inadequate cellular uptake and rapid lysosomal degradation. This study explores the potential of iontophoresis to augment the efficacy of liposome and immunoliposome-based drug delivery systems for SCC treatment. The study assessed iontophoresis effects on SCC cell line (A431) viability, nanoparticle uptake dynamics, and intracellular distribution patterns. Specific inhibitors were employed to delineate cellular internalization pathways, while fluorescence microscopy and immunohistochemistry examined changes in EGFR expression and lysosomal activity. Results demonstrated that iontophoresis significantly increased cellular uptake of liposomes and immunoliposomes, achieving approximately 50 % uptake compared to 10 % with passive treatment. This enhancement correlated with modifications in endocytic pathways, favoring macropinocytosis and caveolin-mediated endocytosis for liposomes, and macropinocytosis and clathrin-mediated pathways for immunoliposomes. Moreover, iontophoresis induced alterations in EGFR distribution and triggered syncytium-like cellular clustering. It also attenuated lysosomal activity, thereby reducing nanoparticle degradation and prolonging intracellular retention of therapeutic agents. These findings underscore the role of iontophoresis in modulating nanoparticle internalization pathways, offering insights that could advance targeted drug delivery strategies and mitigate therapeutic resistance in SCC and other malignancies. •Iontophoresis increased liposome and immunoliposome uptake in SCC cells.•Macropinocytosis facilitated nanoparticle uptake with iontophoresis.•Iontophoresis decreased lysosomal degradation, likely enhancing drug retention.•Iontophoresis led to syncytium-like cell grouping and altered EGFR distribution.•Combined iontophoresis-nanoparticle approach may overcome SCC drug resistance.
ISSN:0927-7765
1873-4367
1873-4367
DOI:10.1016/j.colsurfb.2024.114459